Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-31, Stock:ABBV, The news for the past five days is as follows:
2018-12-21: NEWS1: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS2: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS3: Noteworthy Friday Option Activity: CLVS, ABBV, AAL.NEWS4: Noteworthy Friday Option Activity: CLVS, ABBV, AAL.NEWS5: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS6: Gilead Partners with Scholar Rock for Fibrotic Disease Drugs.NEWS7: Gilead Partners with Scholar Rock for Fibrotic Disease Drugs.
2018-12-24: NEWS1: AbbVie (ABBV) Stock Moves -0.89%: What You Should Know.NEWS2: Lupin, AbbVie To Develop Novel Oncology Drug To Treat Hematological Cancers.NEWS3: Lupin, AbbVie To Develop Novel Oncology Drug To Treat Hematological Cancers.
2018-12-26: NEWS1: Health Care Sector Update for 12/26/2018: CAPR,IMMU,ABBV,NEOS,TEVA.NEWS2: Health Care Sector Update for 12/26/2018: CAPR,IMMU,ABBV,NEOS,TEVA.NEWS3: Health Care Sector Update for 12/26/2018: IMMU,ABBV,NEOS,TEVA.NEWS4: Health Care Sector Update for 12/26/2018: IMMU,ABBV,NEOS,TEVA.NEWS5: Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?.NEWS6: AbbVie Partners Lupin to Boost Hematological Cancer Pipeline.NEWS7: AbbVie Partners Lupin to Boost Hematological Cancer Pipeline.NEWS8: AbbVie Partners Lupin to Boost Hematological Cancer Pipeline.NEWS9: AbbVie Rises 3%.
2018-12-27: NEWS1: AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV.NEWS2: AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV.NEWS3: The Humira Overhang Can’t Cast a Shadow on AbbVie Stock Forever.NEWS4: ABBV February 2019 Options Begin Trading.NEWS5: ABBV February 2019 Options Begin Trading.NEWS6: AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV.
2018-12-28: NEWS1: Friday Sector Leaders: Healthcare, Technology & Communications.NEWS2: Friday Sector Leaders: Healthcare, Technology & Communications.NEWS3: AbbVie: A Low-Risk Income Stock That Gives Investors Exposure to the Marijuana Industry.NEWS4: Noteworthy ETF Inflows: SDY, O, NNN, ABBV.NEWS5: Noteworthy ETF Inflows: SDY, O, NNN, ABBV.NEWS6: Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?.NEWS7: Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?.NEWS8: 2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma.NEWS9: AbbVie Rises 3%.NEWS10: Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?.

Answer: Rise